Amphivena Therapeutics, a subsidiary of Affimed Therapeutics, develops treatments to address hematologic malignancies. Founded by Jeanmarie Guenot and Luke Evnin in 2012, Amphivena Therapeutics is backed by investors that include Aju IB Investment, Merieux Developpement, MPM Capital, NanoDimension, and Qiming Venture Partners and is headquartered in San Francisco.
FOUNDED:
2012
INDUSTRY:
Biotechnology, Health Care, Therapeutics
FOUNDERS:
Jeanmarie Guenot, Luke Evnin
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
